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We sought to clarify pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth.
Colorectal carcinomas resected at Showa University Hospital in Tokyo included 86 with characteristics of polypoid growth (PG) and
21 with those of nonpolypoid growth (NPG). Mutations of APC, Ki-ras, and p53 genes, as well as microsatellite instability (MSI), were
analysed using fluorescence-based polymerase chain reaction–single-strand conformation polymorphism (PCR–SSCP). Carcinomas
with an NPG pattern were smaller than PG tumours (Po0.0001). Carcinomas with a PG pattern were more likely to harbour Ki-ras
mutations (36%) than NPG tumours (0%; Po0.0001). Mutation types in the APC gene differed significantly between PG and NPG
carcinomas (P¼0.0189), including frameshift mutations in 66% of PG carcinomas but no NPG carcinomas. Presence of a p53
mutation at a ‘hot spot’ also was more likely in PG carcinomas (37%) than in NPG carcinomas (0%; P¼0.0124). No significant
difference in presence of MSI was evident between carcinomas with PG and NPG patterns. In conclusion, significant genetic
differences were evident between carcinomas with PG and NPG patterns. Genetic changes in NPG carcinomas differed from those
of the conventional adenoma–carcinoma sequence. Assuming that some nonpolypoid growth lesions transform rapidly into
advanced carcinomas, 20% of all colorectal carcinomas may progress in this manner.
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The distinction between flat or depressed colorectal cancers and
polypoid colorectal cancers now is well accepted endoscopically.
However, the frequency of colorectal carcinomas originating from
a flat or depressed (nonpolypoid) precursor lesion is unknown.
Two pathways for development of colorectal carcinomas have been
proposed, one being the adenoma–carcinoma sequence by which
many carcinomas develop from polypoid adenomas (Morson, 1968;
Muto et al, 1975), and the other involving essentially flat precursor
lesions, often with a central depressed area. Histologically, flat
lesions are more likely to harbour high-grade dysplasia even when
small (Muto et al, 1985). Furthermore, some depressed cancers
may develop de novo (Kuramoto and Ohara, 1988; Kudo, 1993).
In 1990, a multistep genetic model for colorectal tumorigenesis
was proposed (Vogelstein et al, 1988; Fearon et al, 1990; Fearon
and Vogelstein, 1990), in which genetic alterations involving an
oncogene and several tumour suppressor genes accumulate in the
tumour cell lineage. APC gene mutations are involved in the initial
step of adenoma formation, while Ki-ras mutations make
adenomas larger and more severely dysplastic and p53 mutations
promote malignant transformation (Bos et al, 1987; Vogelstein
et al, 1988; Baker et al, 1989; Fearon et al, 1990; Fearon and
Vogelstein, 1990; Miyoshi et al, 1992; Powell et al, 1992). In
another genetic pathway to colorectal neoplasia, microsatellite
instability (MSI) is caused by mutations in nucleotide mismatch
repair genes (Marra and Boland, 1995; Kinzler and Vogelstein,
1996). MSI is characterised by additions and deletions of
nucleotides in numerous repeated nucleotide sequences (micro-
satellites). Patients with MSI-positive colorectal carcinoma have
better survival (Hemminki et al, 2000). Alteration of a 10-base pair
(bp) polyadenine tract in the transforming growth factor-b type II
receptor (TGF-b RII) gene is present in many MSI-positive
carcinomas (Parson et al, 1995; Akiyama et al, 1997). While the
APC, Ki-ras, and p53 genes, as well as MSI, have been
characterised with regard to carcinogenesis in polypoid adenomas,
a specific gene responsible for carcinogenesis in flat adenomas has
not yet been identified.
We encountered a patient in whom a minute depressed lesion
previously had been missed in interpretation of barium enema
radiographs; it transformed rapidly into an advanced carcinoma
with nonpolypoid growth (NPG). In previous studies, some minute
nonpolypoid neoplasias have been reported to transform to
nonpolypoid cancers manifesting rapid growth (Minamoto et al,
1994; Matsumoto et al, 1995; Fujiya and Maruyama, 1997). The
central depression has been reported to be clearly delineated
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yradiographically in 32 out (60.4%) of 53 nonpolypoid neoplasias
measuring 5mm and less (Fujiya and Maruyama, 1997). Matsu-
moto et al (1993) have shown that barium enema examination can
demonstrate small flat and depressed adenomas of the colon,
although colonoscopy seems superior to barium enema examina-
tion for detection of these lesions. The previous barium enema
radiograph indicated depressed area of the tumour alone, but no
elevated portion surrounding depressed area was found in our
case. The histologically entire size of the tumour has been shown
to correspond to the size of the depressed area in barium enema
examination (Matsumoto et al, 1993; Minamoto et al, 1994; Watari
et al, 1997). Thus, the advanced carcinoma in our case was thought
to have truly derived from a minute depressed-type lesion. If flat
lesions containing depressed areas progress rapidly, investigation
of the frequency, morphologic characteristics, and genetic altera-
tions of consequent carcinomas is particularly important. Flat or
depressed lesions are very difficult to identify by conventional
diagnostic techniques (Fujii et al, 1998; Rembacken et al, 2000); if
they develop through distinct genetic pathways, genetic diagnostic
approaches to screen for this type of colorectal neoplasia might
provide more early detection. Assuming that transformation of flat
lesions containing depressed lesions may be rapid, we investigated
the genetic makeup of carcinomas originating from flat lesions
with depressions.
MATERIALS AND METHODS
Initial case
In October 1996, a 53-year-old woman was found to have
occult blood in her stool during screening for colorectal
carcinoma. No abnormality was found in an air-contrast
barium enema radiograph. She had no family history of here-
ditary predisposition to colorectal carcinoma. In October 1997,
she underwent a second examination for stool occult blood. Since
the result again was positive, colonoscopy (Figure 1A) was
performed. An advanced carcinoma of 2.5cm in diameter was
discovered in the transverse colon. The original barium enema
radiographs were carefully re-examined for evidence of the
carcinoma. A small pool of barium, 4mm in diameter, was seen
in the location where the advanced carcinoma subsequently was
detected (Figure 1B). Doubling time was estimated to be 2.4
months. Histologically, the resected tumour was a moderately
differentiated adenocarcinoma infiltrating through the muscularis
propria (Figure 1C) with metastases to regional lymph nodes
(stage III, T3N1M0). This carcinoma was classified as having a
nonpolypoid growth (NPG) pattern according to our previously
published criteria (Kaneko et al, 1998). While no frameshift
mutation of the APC gene and no Ki-ras mutation were present, a
p53 mutation was found in exon 7 (codon 244; base change, GGC
to GAC; amino-acid change, Gly to Tyr). This mutation was not
located within one out of six known ‘hot spots’ for p53 mutations.
No MSI was evident.
Patient selection and data collection
Between April 1996 and March 1998, a total of 132 consecutive
patients with invasive colorectal carcinomas underwent surgical
resection at Showa University School of Medicine, Tokyo. Since the
advanced carcinoma in the index case that originated from a
depressed lesion represented stage III disease with pT3, we decided
to select stage II and III carcinomas with pT3 from these cases. In
all, 18 patients were excluded as the cancers were stage I, and four
with liver metastases were also excluded from the study. Three
patients with synchronous cancers of the colon were excluded
because growth pattern and genetic alterations in such lesions
could differ from that of sporadic carcinomas. None of the patients
had a hereditary predisposition to colorectal carcinoma or other
malignant disease. The final study group consisted of these 107
sporadic stage II or III colorectal carcinomas. Pathological features
were evaluated by a pathologist at our hospital. Tumour size and
location were determined from operative reports, and from clinical
and pathologic data where applicable.
Figure 1 Findings in the presented case. (A) Colonoscopy. The tumour
was relatively low and flat, with shallow central depression. (B) Magnified
view of previous barium enema radiograph obtained 1 year previously. A
small pool of barium 4mm in diameter was present in the left portion of
the transverse colon (arrow). (C) Low-power view of histologic findings in
the lesion. At its border, the cancer was covered with normal mucosa
accompanied by muscularis mucosa (arrow). This lesion was classified as
showing nonpolypoid growth (NPG) type.
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Some minute nonpolypoid intramucosal neoplasias have been
reported to transform to nonpolypoid invasive cancers (Minamoto
et al, 1994; Matsumoto et al, 1995; Fujiya and Maruyama, 1997). In
our previous study, almost all of NPG carcinomas infiltrating the
submucosa were macroscopically flat and depressed carcinomas
(Kaneko et al, 1998). We thought that PG and NPG carcinomas
infiltrating the submucosa would progress PG and NPG carcino-
mas infiltrating beyond the submucosa. The histologic interface
between the carcinoma and the surrounding normal epithelium
was carefully studied. Depending on appearance, the carcinomas
were classified as having a polypoid growth (PG) or nonpolypoid
growth (NPG) pattern (Figure 2A–C). Details of this assessment
have been described previously (Kaneko et al, 1998). Briefly,
formalin-fixed surgical specimens were cut into blocks 5mm in
thickness and embedded in paraffin for sectioning. The appear-
ance of the junction between carcinoma and normal mucosa was
assessed in four or five locations for each carcinoma after sections
were stained with haematoxylin and eosin (H and E). A pathologist
(MK) assigned each cancer to the PG or NPG group. In carcinomas
with a PG pattern, the malignant tumour rose abruptly from
adjacent normal mucosa. In contrast, carcinomas with an NPG
pattern showed a junction covered by normal mucosa and
muscularis mucosa. The mucosa covering the junction either
exhibited normal tissue or contained atypical cells.
Analysis of gene mutations
DNA samples were extracted from tissue obtained at operation and
frozen at  801C until use. Ki-ras codon 12 and 13 mutations were
analysed using polymerase chain reaction–single-strand confor-
mation polymorphism (PCR–SSCP). To facilitate comparison with
our previous data, the primers and PCR conditions for analysis of
Ki-ras mutations were the same as those described previously
(Sugano et al, 1993; Kaneko et al, 1998; Kaneko et al, 2000).
Mutations of the APC and p53 genes were analysed by
fluorescence-based PCR–SSCP analysis with low-pH buffer
(Kukita et al, 1997) using an ALF Express DNA sequencer
(Amersham Pharmacia Biotech, Uppsala, Sweden) (Makino et al,
2000). Multiple overlapping primers were used to generate 250- to
400-bp PCR products spanning codons 1256–1640 of the APC
gene; this site is known as a mutation cluster region (MCR), since a
significant proportion of mutations cluster in a small region of
exon 15. The reported prevalence of somatic mutations in the MCR
ranges from 45 to 60% in colorectal tumours to 100% in desmoid
tumours (Miyoshi et al, 1992; Miyaki et al, 1993). Based on these
observations, we chose to screen for APC mutations in the MCR in
our study. Primers G, H, and I in exon 15 of the APC gene were
used as described previously (Groden et al, 1991). PCR was
performed for 30 cycles (941C for 30s, 551C for 30s, 721C for
1min) with primer G, and for 30 two-step cycles (951C for 20s,
651C for 2min) with primers H and I. The primers and PCR
conditions for exons 5–8 of the p53 gene were the same as those
used previously (Makino et al, 2000). Furthermore, MSI (Boland
et al, 1998) of TGF-bRII, BAT 26, BAT 40, D2S123, and D13S175
was analysed by fluorescence based-PCR–SSCP analysis with low-
pH buffer using the ALF Express DNA sequencer. High instability
(MSI-H) was defined by a novel bandshift or allele in at least 30%
of microsatellite loci tested when compared to non-neoplastic
tissue from the same patient (Boland et al, 1998). Low instability
(MSI-L) designated cases with over 0% but less than 30% of
markers showing a novel allele. The 50-terminus of each primer
was labelled with Cy5 dye (Amersham Pharmacia Biotech). A
measure of 50ng of DNA was used for the PCR reaction. Amplified
PCR fragments were analysed by the ALF Express DNA sequencer
with 5% polyacrylamide gel (acrylamide:bis/49:1) containing
1 TME (30ml Tris base, 36mM 2[N-morpholino] ethanesulpho-
nic acid (MES) and 1mM EDTA, pH 6.8). As described previously
(Makino et al, 2000), mutations were analysed with the Fragment
manager program; shifted peaks were considered to represent
DNA fragments that contained a mutation. DNA sequencing of
samples that showed shifted peaks was carried out as described
previously (Makino et al, 2000). A clear peak shift could be
Figure 2 Low-power views of histologic findings in polypoid growth
(PG; panel A) and nonpolypoid growth (NPG; panel B), type of
carcinomas infiltrating to the submucosa, including endoscopic correlation
for NPG (C). (A) At the border of the lesion, the cancer rises abruptly
from normal mucosa. (B) At the border of the lesion, the cancer is covered
with normal mucosa accompanied by muscularis mucosa. (C) Endoscopic
view of NPG carcinoma. The lesion shows relatively little elevation, and has
a central depression.
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of PCR–SSCP under our conditions was 100% compared with
DNA sequences as described previously (Makino et al, 2000).
Direct sequencing was performed in cases that were negative by
SSCP, since the presence of missed mutations in the SSCP-negative
cases could not otherwise be ruled out. Sample collection and gene
analysis in this study were approved by the Human Ethics Review
Committee of Showa University School of Medicine.
Statistical analysis
Data used for classifying growth patterns of colorectal carcinomas
into the PG and NPG patterns were not considered in the genetic
and clinicopathologic analyses; to avoid bias, these data were
uncoded only afterward. The significance of differences in
proportions was assessed by the w
2-test, Fisher’s exact test, or
the Wilcoxon rank-sum test. Multivariate analyses were performed
using a multiple logistic regression. P-values less than 0.05 were
considered to indicate significance.
RESULTS
As shown in Table 1, the incidence of vascular invasion in NPG
carcinomas was significantly higher than that in PG carcinomas.
NPG carcinomas were significantly smaller than PG carcinomas.
Mean age, gender, location of tumour, tumour differentiation,
lymph node metastasis, and proportion of stage II and III did not
differ significantly between PG and NPG carcinomas.
As shown in Table 2, Ki-ras mutation was found in 36% of PG
carcinomas, while no mutation was found in NPG carcinomas.
Differences from the wild-type sequence were as follows: Gly to
Ala, 3 (10%); Gly to Gly, 0 (0%); Gly to Cys, 2 (6%); Gly to Ser, 1
(3%); Gly to Val, 14 (45%); Gly to Asp, 10 (32%); and Gly to Arg, 1
(3%). The frequency of Gly-to-Val mutation at codon 12 was high
in PG carcinomas (14 out of 31, 45%).
Prevalence of an APC mutation did not differ significantly
between PG and NPG carcinomas (Table 2). As shown in Table 3,
the frequency of frameshift mutation was higher in PG carcinomas
(66%) than in NPG carcinomas (0%). Mutation types of the APC
gene in PG carcinomas differed significantly from those in NPG
carcinomas.
Overall prevalence of a p53 mutation did not differ significantly
between PG and NPG carcinomas (Table 2). As shown in Table 3,
types of mutation of the p53 gene in PG carcinoma did not differ
significantly from those in NPG carcinoma. However, involvement
of hot spots differed greatly. Of 49 mutations in PG carcinomas, 18
(37%) were found in hot spots at codon 175 (four patients), 245
Table 1 Clinicopathologic characteristics of PG and NPG carcinomas
PG carcinoma
(n¼86)
NPG carcinoma
(n¼21) P-value
Age, years
Mean (range) 64.7 (42–83) 65.1 (43–82) NS
Gender
Male 44 (51%) 11 (52%) NS
Female 42 (49%) 10 (48%)
TNM classification
Stage II 37 (43%) 8 (38%) NS
Stage III 49 (57%) 13 (62%)
Tumour location
Right 31 (36%) 8 (38%) NS
Left 55 (64%) 13 (62%)
Tumour differentiation
Well 50 (58%) 8 (38%) NS
Moderately 26 (30%) 9 (43%)
Poorly 10 (12%) 4 (19%)
Size, mm
Mean (range) 55 (25–80) 33 (10–55) o0.0001
Lymph node metastasis
Presence 49 (57%) 13 (62%) NS
Absence 37 (43%) 8 (38%)
Vascular invasion
Presence 64 (74%) 20 (95%) 0.0370
Absence 22 (26%) 1 (5%)
PG ¼ polypoid growth type; NPG ¼ nonpolypoid growth type; NS ¼ not
significant (PX0.05).
Table 2 Genetic changes in PG and NPG carcinomas
PG carcinoma
(n¼86)
NPG carcinoma
(n¼21) P-value
APC mutation
Presence 29 (34%) 5 (24%) 0.3818
Absence 57 (66%) 16 (76%)
Ki-ras mutation
Presence 31 (36%) 0 (0%) o0.0001
Absence 55 (64%) 21 (100%)
p53 Mutation
Presence 48 (56%) 12 (57%) 0.9124
Absence 38 (44%) 9 (43%)
MSI
Presence 14 (16%) 3 (14%) 0.9806
Absence 72 (84%) 18 (86%)
PG ¼ polypoid growth type; NPG ¼ nonpolypoid growth type; MSI ¼
microsatellite instability.
Table 3 Mutation patterns of APC and p53 genes in PG and NPG
carcinomas
PG carcinoma NPG carcinoma P-value
APC mutation
Type 29 (100%) 5 (100%)
Nonsense 9 (31%) 4 (80%) 0.0189
Missense 1 (3%) 1 (20%)
Frameshift 19 (66%) 0 (0%)
p53 Mutation
Type 49 (100%)* 12 (100%)
Nonsense 5 (10%) 3 (25%) 0.1805
Missense 35 (71%) 5 (42%)
Frameshift 6 (12%) 4 (32%)
Splice site 2 (4%) —
Silent 1 (2%) —
Hot-spot mutation
Presence 18 (37%) 0 (0%) 0.0124
Absence 31 (63%) 12 (100%)
MSI
Degree 14 (100%) 3 (100%)
MSI-H 7 (50%) 1 (33%) 0.8808
MSI-L 7 (50%) 2 (67%)
PG ¼ polypoid growth type; NPG ¼ nonpolypoid growth type; MSI ¼
microsatellite instability; MSI-H ¼ high instability (two or more out of five loci);
MSI-L ¼ low instability (one out of five loci); * ¼ 49 mutations in 48 PG carcinomas
(one case having two mutations, one nonsense, and one frameshift).
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(one patient); no patient had a mutation at codon 249. In contrast,
the 12 p53 mutations in NPG carcinomas were not found at hot
spots. The prevalence of p53 mutations at hot spots thus was
significantly higher in PG carcinomas than in NPG carcinomas
(Table 3). Direct sequencing performed on all cases that were
negative by SSCP did not disclose any mutations. The sensitivity
and specificity of the PCR–SSCP assay for the mutations were 100
and 90%, respectively.
No MSI was found in non-neoplastic tissue from any of the 107
patients. The frequency of MSI in PG carcinomas did not differ
significantly from that in NPG carcinomas (Table 2). The
frequency of patients showing instability at all five loci was five
out of 17 (29%); four out of five loci, no patient (0%); three out of
five loci, one patient (6%); two out of five loci, two patients (12%);
and one out of five loci, nine patients (53%). All five patients with
an abnormality of TGF-bRII also had abnormalities at the other
four loci, and all five patients had PG carcinomas. Of eight MSI-H
tumours, seven (88%) were PG carcinomas. Of three NPG
carcinomas with MSI (Table 3), one was MSI-H (three of five
loci); the remaining two were MSI-L (one out of five loci).
Multivariate analyses were performed using multiple logistic
regression. Tumours were classified as PG or NPG carcinomas, and
these groups were compared concerning patient age, gender,
clinical stage, tumour size, vascular invasion, tumour location,
tumour differentiation, APC mutation, Ki-ras mutation, p53
mutation, and MSI. Significant differences were evident for tumour
size (P¼0.00002) and vascular invasion (P¼0.02417). Presence of
a Ki-ras mutation showed a significant difference between PG and
NPG carcinomas in univariate analysis (Po0.0001). This differ-
ence was not evident by multiple logistic regression (P¼0.99995)
because no Ki-ras mutation was found in NPG carcinomas.
DISCUSSION
This study was prompted by the apparently rapid progression of a
minute depressed lesion to an advanced nonpolypoid growth
carcinoma within only 1 year. We propose that colorectal
neoplasias with a central depression develop into carcinomas with
a nonpolypoid growth pattern.
In our previous prospective study in which 2720 consecutive
patients undergoing total colonoscopy were examined for flat
lesions, a Ki-ras mutation was not found in any intramucosal flat
lesion with a smooth surface (Kaneko et al, 2000). In another
previously published study, we found no Ki-ras mutation in NPG
carcinomas infiltrating the submucosa (SM) (Kaneko et al, 1998).
SM-NPG carcinomas showed neither a coexisting adenomatous
component nor a Ki-ras mutation. In contrast, 75% of SM-PG
carcinomas had a coexisting adenomatous component, and 44%
had a Ki-ras mutation. We reported that SM-PG carcinomas arose
from protruding adenomas according to the adenoma–carcinoma
sequence, while the growth pattern of SM-NPG carcinomas was
different. Vogelstein et al (1988) proposed that Ki-ras mutation is
an early event in the adenoma–carcinoma sequence with Ki-ras
mutational status possibly determining development of an
exophytic polypoid adenoma. Our results suggest that in contrast
a Ki-ras mutation might not be present in the NPG carcinoma
pathway even when the lesion is advanced. Our previous and
present studies indicate that Ki-ras mutation is not related to
genetic progression in morphologically distinct nonpolypoid
lesions containing NPG carcinomas.
Our study showed that NPG carcinomas were significantly
smaller than PG carcinomas. In spite of this, vascular invasion was
significantly more frequent in NPG carcinomas than in PG
carcinomas. It is likely that the biologic behaviour of NPG
carcinomas is more aggressive than that of PG carcinomas. Many
reports have analysed that flat and depressed lesions have a higher
malignant potential than polypoid lesions, since flat and depressed
lesions readily infiltrate deeper layers despite their small size
(Crowford and Stromeyer, 1983; Wolber and Owen, 1991; Lanspa
et al, 1992; Jaramillo et al, 1994; Rubio et al, 1994; Kudo et al,
1995a,b; Mitooka et al, 1995; Yokota et al, 1995; Fujii et al, 1998;
Hart et al, 1998; Rembacken et al, 2000; Saito et al, 2001). A greater
malignant potential in NPG carcinomas than in PG carcinomas is
analogous to flat lesions containing depressed areas having greater
malignant potential than polypoid adenomas.
Mutation patterns in the APC gene differed significantly between
PG and NPG carcinomas. More than 700 somatic mutations of the
APC gene have been reported to date in different tumour types,
with more than 90% of these mutations being observed in
colorectal adenomas according to Laurent-Puig et al (1998). The
same authors reported that most of these somatic mutations led to
truncation of the APC protein, either by frameshift mutation (62%)
or by nonsense mutation (34%). The proportion of frameshift and
nonsense mutations in the report of Laurent-Puig et al was similar
to that in PG carcinomas in our study. In our study, however, no
frameshift mutation was found in NPG carcinomas. Other group
has reported similar findings (De Benedetti et al, 1994). De
Benedetti et al (1994) reported that frameshift mutation of APC
gene was predominant in polypoid adenomas, with APC mutations
participating in progression of exophytic adenomas. In contrast,
Umetani et al (2000) have reported that the frequency of APC
mutation in nonpolypoid adenomas was significantly lower than
that in polypoid adenomas, while being similar between polypoid
carcinomas and nonpolypoid carcinomas. They concluded that
new APC mutations are acquired at the time point representing
malignant transformation during the development of nonpolypoid
adenomas. We believe that APC mutations in NPG carcinomas are
related to malignant transformation, since we found no significant
difference in frequency of APC mutations between PG and NPG
carcinomas. Yet we found no APC frameshift mutations in NPG
carcinomas. If the presence of APC mutations in NPG carcinomas
is indeed related to malignant transformation, we suspect that
specific mutation patterns of the APC gene importantly affect the
genetic pathway leading to NPG carcinoma.
With respect to the p53 gene, 6177 somatic mutations in exons 5
to 8 have been reported in different tumour types (Hussain and
Harris, 1999). The overall prevalence of nonsense, missense,
frameshift, splice site, and silent mutations among these 6177
mutations was 6, 78, 10, 3, and 3%, respectively. These relative
prevalences were similar to those in our PG and NPG tumours. In
contrast, mutation of the p53 gene has been proposed to be
concentrated at hot spots (Hainnaut et al, 1998; Hussain and
Harris, 1999). Mutations were found at one or more of six hot
spots in exons 5–8 in 25–30% of large case series (Greenblatt et al,
1994; Hainnaut et al, 1998; Hussain and Harris, 1999); similarly,
the prevalence in all of our cases considered together was 28%. Hot
spots for somatic mutations in carcinomas represent protein
alterations that provide a selective growth advantage to the cell.
Many reports suggest that a hot spot can identify relationships
between mutation, protein structure and function, and carcino-
genesis (Hsu et al, 1991; Cho et al, 1994; Greenblatt et al, 1994;
Tornaletti and Pfeifer, 1994). In this study, no hot-spot mutations
were found in NPG carcinomas. The difference in p53 mutation
location between PG and NPG carcinomas may suggest differences
in function correlating with differing morphologic development.
The frequency of MSI did not differ significantly between our PG
and NPG carcinomas, although most carcinomas rated MSI-H were
PG carcinomas (88%). Loukola et al (1999) examined MSI in 402
sporadically occurring adenomas, with only six adenomas (1.5%)
being MSI-H. Furthermore, five of these six adenomas subse-
quently proved to have arisen in subjects with hereditary
nonpolyposis colorectal cancer (HNPCC). In our study, eight out
of 107 carcinomas (7%) were MSI-H; most carcinomas rated MSI-
H were PG carcinomas, which were considered to have arisen from
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commonly observed in dysplastic areas of serrated polyps, as was
MSI-L. We believe that PG carcinomas may include most
carcinomas derived from serrated adenomas.
Clinicopathologic findings in our study suggest that develop-
ment of NPG carcinomas is more aggressive than that of PG
carcinomas. The genetic makeup of NPG carcinomas is unique, not
being based on the conventional adenoma–carcinoma sequence.
We suggest that the genetic pathway of NPG carcinoma is distinct
from that of PG carcinoma even in early stages of carcinogenesis.
The morphologic characteristics of carcinomas originating from
nonpolypoid lesions may reflect differences in genetic pathways
giving rise to cancers. Furthermore, some minute nonpolypoid
neoplasias have reported previously to transform to nonpolypoid
cancers manifesting rapid growth (Minamoto et al, 1994;
Matsumoto et al, 1995; Fujiya and Maruyama, 1997). If we assume
that some flat or depressed lesions rapidly transform into
advanced nonpolypoid growth carcinomas, a maximum of 20%
of colorectal carcinomas could be expected to progress in this
manner.
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